Mutational analysis of Phe160 within the 'palm' subdomain of human immunodeficiency virus type 1 reverse transcriptase

Journal of Molecular Biology

Volumn 290, Issue 3, 1999, Pages 615-625

  Gutiérrez Rivas, Mónica ^a   Ibá Ñ, Ángela ^b   Martínez, Miguel A ^b   Domingo, Esteban ^a   Menéndez Arias, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

AIDS; HIV 1; Nucleotides; Polymerase; Reverse transcriptase

Indexed keywords

ALANINE; GLUTAMINE; ISOLEUCINE; PHENYLALANINE; RNA DIRECTED DNA POLYMERASE; TRYPTOPHAN; TYRAMINE;

ACCURACY; AMINO ACID SUBSTITUTION; ARTICLE; CRYSTAL STRUCTURE; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SPECIFICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0040578732     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2880     Document Type: Article

References (43)

1. Arts E. J., Wainberg M. A. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription. Antimicrob. Agents Chemother. 40:1996;527-540.
2. Birdsall D. L., Finer-Moore J., Stroud R. M. Entropy in bi-substrate enzymes: proposed role of an alternate site in chaperoning substrate into, and products out of, thymidylate synthase. J. Mol. Biol. 255:1996;522-535.
3. Boyer P. L., Ferris A. L., Hughes S. H. Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 66:1992;1031-1039.
4. Burley S. K., Petsko G. A. Aromatic-aromatic interactions: a mechanism of protein structure stabilization. Science. 229:1985;23-28.
5. Di Marzo Veronese F., Copeland T. D., DeVico A. L., Rahman R., Oroszlan S., Gallo R. C., Sarngadharan M. G. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science. 231:1986;1289-1291.
6. Ding J., Das K., Hsiou Y., Sarafianos S. G., Clark A. D. Jr, Jacobo-Molina A., Tantillo C., Hughes S. H., Arnold E. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 Å resolution. J. Mol. Biol. 284:1998;1095-1111.
7. Drosopoulos W. C., Prasad V. R. Increased misincorporation fidelity observed for nucleoside analog resistance mutations M184V and E89G in human immunodeficiency virus type 1 reverse transcriptase does not correlate with the overall error rate measured in vitro. J. Virol. 72:1998;4224-4230.
8. Gao G., Orlova M., Georgiadis M. M., Hendrickson W. A., Goff S. P. Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection. Proc. Natl Acad. Sci. USA. 94:1997;407-411.
9. Gu Z., Fletcher R. S., Arts E. J., Wainberg M. A., Parniak M. A. The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2′,3′-dideoxycytidine, 2′,3′-dideoxy-3′-thiacytidine, and 2′,3′-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro. J. Biol. Chem. 269:1994;28118-28122.
10. Hamburgh M. E., Drosopoulos W. C., Prasad V. R. The influence of 3TC-resistance mutations E89G and M184V in the human immunodeficiency virus reverse transcriptase on mispair extension efficiency. Nucl. Acids Res. 26:1998;4389-4394.
11. Harris D., Kaushik N., Pandey P. K., Yadav P. N. S., Pandey V. N. Functional analysis of amino acid residues constituting the dNTP binding pocket of HIV-1 reverse transcriptase. J. Biol. Chem. 273:1998;33624-33634.
12. Hostomsky Z., Hostomska Z., Fu T.-B., Taylor J. Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis. J. Virol. 66:1992;3179-3182.
13. Hsu M., Inouye P., Rezende L., Richard N., Li Z., Prasad V. R., Wainberg M. A. Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1. Nucl. Acids Res. 25:1997;4532-4536.
14. Huang H., Chopra R., Verdine G. L., Harrison S. C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance. Science. 282:1998;1669-1675.
15. Hunter C. A., Singh J., Thornton J. M. π-π interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins. J. Mol. Biol. 218:1991;837-846.
16. Jacobo-Molina A., Ding J., Nanni R. G., Clark A. D. Jr, Lu X., Tantillo C., Williams R. L., Kamer G., Ferris A. L., Clark P., Hizi A., Hughes S. H., Arnold E. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl Acad. Sci. USA. 90:1993;6320-6324.
17. Kaushik N., Rege N., Yadav P. N. S., Sarafianos S. G., Modak M. J., Pandey V. N. Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase. Biochemistry. 35:1996;11536-11546.
18. Kaushik N., Harris D., Rege N., Modak M. J., Yadav P. N. S., Pandey V. N. Role of Glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA-synthesis. Biochemistry. 36:1997;14430-14438.
19. Kellam P., Larder B. A. Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. Antimicrob. Agents Chemother. 38:1994;23-30.
20. Kohlstaedt L. A., Wang J., Friedman J. M., Rice P. A., Steitz T. A. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 256:1992;1783-1790.
21. Larder B. A., Kemp S. D., Purifoy D. J. M. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Proc. Natl Acad. Sci. USA. 86:1989;4803-4807.
22. Le Grice S. F. J., Naas T., Wohlgensinger B., Schatz O. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J. 10:1991;3905-3911.
23. Lightfoote M. M., Coligan J. E., Folks T. M., Fauci A. S., Martin M. A., Venkatesan S. Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J. Virol. 60:1986;771-775.
24. Martín-Hernández A. M., Domingo E., Menéndez-Arias L. Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis. EMBO J. 15:1996;4434-4442.
25. Martín-Hernández A. M., Gutiérrez-Rivas M., Domingo E., Menéndez-Arias L. Mispair extension fidelity of human immunodeficiency virus type 1 reverse transcriptases with amino acid substitutions affecting Tyr115. Nucl. Acids Res. 25:1997;1383-1389.
26. Menéndez-Arias L. Studies on the effects of truncating α-helix E′ of p66 human immunodeficiency virus type 1 reverse transcriptase on template-primer binding and fidelity of DNA synthesis. Biochemistry. 37:1998;16636-16644.
27. Nakamura T. M., Morin G. B., Chapman K. B., Weinrich S. L., Andrews W. H., Lingner J., Harley C. B., Cech T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
28. Oude Essink B. B., Back N. K. T., Berkhout B. Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. Nucl. Acids Res. 25:1997;3212-3217.
29. Pandey V. N., Kaushik N., Rege N., Sarafianos S. G., Yadav P. N. S., Modak M. J. Role of Methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis. Biochemistry. 35:1996;2168-2179.
30. Poch O., Sauvaget I., Delarue M., Tordo N. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 8:1989;3867-3874.
31. Rezende L. F., Drosopoulos W. C., Prasad V. R. The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase. Nucl. Acids Res. 26:1998;3066-3072.
32. Sarafianos S. G., Pandey V. N., Kaushik N., Modak M. J. Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase. Biochemistry. 34:1995a;7207-7216.
33. Sarafianos S. G., Pandey V. N., Kaushik N., Modak M. J. Site-directed mutagenesis of Arginine 72 of HIV-1 reverse transcriptase. Catalytic role and inhibitor sensitivity. J. Biol. Chem. 270:1995b;19729-19735.
34. H-rascomplexed with caged GTP and mant dGppNHp. J. Mol. Biol. 253:1995;132-150.
35. Singh J., Thornton J. M. The interaction between phenylalanine rings in proteins. FEBS Letters. 191:1985;1-6.
36. Sousa R. Structural and mechanistic relationships between nucleic acid polymerases. Trends Biochem. Sci. 21:1996;186-190.
37. Tantillo C., Ding J., Jacobo-Molina A., Nanni R. G., Boyer P. L., Hughes S. H., Pauwels R., Andries K., Janssen P. A. J., Arnold E. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase: implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 243:1994;369-387.
38. Telesnitsky A., Goff S. P. Reverse transcription and the generation of retroviral DNA. Coffin J., Hughes S. H., Varmus H. Retroviruses. 1997;121-160 Cold Spring Harbor Laboratory Press, Plainview.
39. Thoden J. B., Frey P. A., Holden H. M. Molecular structure of the NADH/UDP-glucose abortive complex of UDP-galactose 4-epimerase from Escherichia coli: implications for the catalytic mechanism. Biochemistry. 35:1996;5137-5144.
40. Wainberg M. A., Drosopoulos W. C., Salomon H., Hsu M., Borkow G., Parniak M., Gu Z., Song Q., Manne J., Islam S., Castriota G., Prasad V. R. Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science. 271:1996;1282-1285.
41. Wakefield J. K., Jablonski S. A., Morrow C. D. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome. J. Virol. 66:1992;6806-6812.
42. Wilson J. E., Aulabaugh A., Caligan B., McPherson S., Wakefield J. K., Jablonski S., Morrow C. D., Reardon J. E., Furman P. A. Human immunodeficiency virus type-1 reverse transcriptase. Contribution of Met184 to binding of nucleoside 5′-triphosphate. J. Biol. Chem. 271:1996;13656-13662.
43. Wrobel J. A., Chao S.-F., Conrad M. J., Merker J. D., Swanstrom R., Pielak G. J., Hutchison C. A. III. A genetic approach for identifying critical residues in the fingers and palm subdomains of HIV-1 reverse transcriptase. Proc. Natl Acad. Sci. USA. 95:1998;638-645.